EASL is pushing for EU policy development in areas relevant to liver disease, such as public health, research, communicable diseases (viral hepatitis), nutrition and obesity, alcohol, cancer, rare diseases, organ donation and transplantation to take liver disease into account.
On 24 May 2010, the 63rd World Health Assembly, brought together Health Ministers and senior health officials from the World Health Organization (WHO) Member States and concluded business with delegates adopting resolutions on a variety of global health issues. The details of two of the resolutions of particular interest to EASL, can be found below:
* Resolution WHA63.13 on Global strategy to reduce the harmful use of alcohol
* Resolution WHA63.18 on Viral hepatitis
Learn more about EASL's advocacy activities here. For an outline of each policy area, how each is relevant to liver disease and how EASL has positioned itself in the debate, click on the different hepatocytes below.
